Nashville, TN, United States of America

Jorge H Capdevila


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1998-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Jorge H Capdevila

Introduction

Jorge H Capdevila is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of hypertension detection through innovative methods. With a total of 5 patents, his work focuses on the assessment of arachidonic acid metabolites and their role in hypertension.

Latest Patents

One of his latest patents is titled "Detection of hypertension using glucuronidated metabolic products." This invention outlines a method for assessing arachidonic acid (AA) metabolites-dependent hypertension by measuring glucuronidated dihydroxyeicosatrienoic acids (DHETs) and their metabolites in biological samples. The method utilizes various techniques, including GC/MS, LC/MS, or ELISA, to identify unique epitopes associated with DHET. An example of the glucuronidated DHET metabolite includes DHET-alcohols, such as omega or omega-1 oxidated DHET and DHET esterified glycerol. This innovative approach is particularly useful for drug development and monitoring the effectiveness of treatments for mammals suffering from AA epoxygenase-, epoxide hydrolase-, and/or UDP-glucuronosyl transferase-dependent hypertension.

Career Highlights

Throughout his career, Jorge has worked with various organizations, including Detroit R & D, Inc. His experience in research and development has allowed him to contribute significantly to the understanding and detection of hypertension.

Collaborations

Jorge has collaborated with notable professionals in his field, including Hyesook Kim and Deanna Kroetz. These partnerships have enhanced the quality and impact of his research.

Conclusion

Jorge H Capdevila's innovative work in hypertension detection showcases his expertise and dedication to advancing medical science. His contributions are vital for improving drug development and treatment monitoring in hypertension management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…